Clinical trial
Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in…
NCT00031096 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00031096 |
|---|---|
| Title | Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne |
| Official title | A 12-week, Randomized, Double-blind, Multicenter Study Comparing the Clinical Efficacy and Safety of Azelaic Acid 15% Gel (SH H 655 BA) With Its Vehicle (SH H 655 PBA) in Patients With Mild to Moderate Acne. |
| Lead sponsor | LEO Pharma, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acne Vulgaris |
| Intervention type | Drug |
| Interventions | Azelaic Acid Gel 15% (Finacea, BAY39-6251), Vehicle gel (SH H 655 PBA) |
| Enrollment | 879 |
| Start date | Jan 1, 2002 |
| Primary completion | Jul 1, 2002 |
| Completion | Jul 1, 2002 |
| First posted | Feb 22, 2002 |
| Last update posted | Jun 9, 2023 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: